By targeting and disabling a protein frequently found in melanoma tumors, doctors may be able to make the cancer more vulnerable to chemotherapy, according to early results of a clinical study conducted by researchers in the Duke Comprehensive Cancer Center.
Full article >>
Friday, March 6, 2009
Drug combination may be effective against deadly melanoma, pilot study shows
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment